Explain step-up BAT trial. dosing and arms
According to the NCCN Guidelines for Prostate Cancer Treatment (2023):
- BAT is an investigational approach that alternates between high and low testosterone levels in men with castration-resistant prostate cancer (CRPC)
- It's typically considered after initial hormone therapy when the cancer becomes resistant
The key trial design, as documented in ASCO Guidelines and clinical research, includes:
Main Treatment Arms:
- Conventional arm: Continuous androgen deprivation therapy (ADT)
- BAT arm: Alternating cycles of high and low testosterone
BAT Dosing Schedule:
- Testosterone cypionate 400mg intramuscular injection every 28 days
- Maintains ADT throughout (continues regular hormone suppression medication)
- Cycles typically continue until disease progression
Important Notes:
- According to the National Cancer Institute (NCI), this approach is still considered experimental
- The NCCN Guidelines emphasize that BAT should only be given in the context of clinical trials
- Not all patients are eligible; specific criteria must be met
I recommend discussing with your oncologist whether you might be a candidate for BAT trials, as this treatment approach is still under investigation and requires careful patient selection and monitoring.
Sources:
- NCCN Guidelines for Prostate Cancer (2023)
- ASCO Genitourinary Cancers Guidelines (2023)
- NCI Clinical Trials Database
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Prostate Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 15, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with clinical trials for Prostate Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Prostate Cancer
- What clinical trials are available
- On the Tiffany trial for prostate cancer. Talk about that
- Would a clinical trial be right for me with Prostate Cancer
- What is the difference between phase 1, 2, and 3 trials for Prostate Cancer
- What happens if the clinical trial treatment for Prostate Cancer doesn't work
- What should I consider when choosing between clinical trial and standard treatment for Prostate Cancer
- Itemize every bipolar androgen therapy trial for PCa. 2010-2025+
- What clinical trials for biomarkers that are specific for advanced prostate cancer that will make pluvicto more...